跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension - TGA Drug Approval Details
Approvals
/
TGA
/
TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension
Approved
STANDARD
TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension
Roche Products Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
0b4f3794fde073fc
Company
Roche Products Pty Ltd
Type
Standard
Approval Details
Approval Id
0b4f3794fde073fc
Product Name
TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension
Artg Id
188016
Artg Name
TAMIFLU oseltamivir (as phosphate) 6 mg/mL powder for oral suspension
Sponsor
Roche Products Pty Ltd
Company Detail Path
/organization/roche-products-pty-ltd
Artg Date
2012-05-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7952bccbd84f77e6e74feb5d9a52ac98.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/db71655b5004e10b33ad6b2e9d52c37d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
0b4f3794fde073fc
Type
Standard
Back to TGA Approvals